Human genome sciences pre market gap fda benlysta news pending (hgsi)

Human genome sciences pre market gap fda benlysta news pending (hgsi)

Human Genome Sciences Pre Market Gap FDA Benlysta News Pending (HGSI). HGSI had increased price action and volatility as the stock spiked to $29.48 in pre market trading as the FDA released it’s 133 page FDA Briefing Information, Belimumab (BENLYSTA), for the November 16, 2010 Meeting of the Arthritis Advisory Committee which addressed Guidance for Industry Systemic Lupus Erythematosus — Developing Medical Products for Treatment, Guidance for Industry: Lupus Nephritis Caused by Systemic Lupus Erythematosus — Developing Medical Products for Treatment, Draft Guidance…



Human genome sciences pre market gap fda benlysta news pending (hgsi)